International Congress on Peer Review in Biomedical Publication. Prague, CZE, 1997/09.
Journal policies and requirements of funding agencies on financial disclosure of authors and grant applicants have divided editors and scientists who disagree on whether such policies can improve the integrity of science or manage conflicts of interest.
Those opposed to such disclosure policies argue that financial interest is one of many interests held by scientists, is the least scientifically dangerous, and should not be singled out.
Those who favor open reporting of financial interests argue that full disclosure removes the suspicion that something of relevance to objectivity is being hidden and allows readers to form their own opinions on whether a conflict of interest exists and what relevance that has to the study.
The authors believe that the scientific community and the public will be best served by open publication of financial disclosures for readers and reviewers to evaluate.
Mots-clés Pascal : Article, Médecine, Intérêt commercial, Transparence, Homme, Littérature scientifique
Mots-clés Pascal anglais : Article, Medicine, Commercial use, Transparency, Human, Scientific literature
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0445683
Code Inist : 002B30A09. Création : 25/01/1999.